Title : Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release.

Pub. Date : 2018 Apr

PMID : 29541457






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release. Ristocetin heat shock protein family B (small) member 1 Homo sapiens
2 Ristocetin induces phosphorylated-HSP27 (HSPB1) release from the platelets of type 2 DM patients: Anti-platelet agent-effect on the release. Ristocetin heat shock protein family B (small) member 1 Homo sapiens
3 In the present study, we investigated the effect of ristocetin, a glycoprotein (GP)Ib/IX/V activator, on the release of HSP27 and the effect of anti-platelet agents, such as acetylsalicylic acid (ASA), on this release. Ristocetin heat shock protein family B (small) member 1 Homo sapiens
4 On the other hand, the levels of phosphorylated-HSP27 induced by ristocetin in the platelets from a patient of the anti-platelet group taking ASA were significantly lower than those from a patient of the control group. Ristocetin heat shock protein family B (small) member 1 Homo sapiens
5 The levels of HSP27 release from the ristocetin-stimulated platelets were significantly correlated with the levels of phosphorylated-HSP27 in the platelets from patients in the two groups. Ristocetin heat shock protein family B (small) member 1 Homo sapiens
6 The levels of HSP27 release from the ristocetin-stimulated platelets were significantly correlated with the levels of phosphorylated-HSP27 in the platelets from patients in the two groups. Ristocetin heat shock protein family B (small) member 1 Homo sapiens
7 These results strongly suggest that anti-platelet agents inhibit the HSP27 release from platelets stimulated by ristocetin but not the aggregation in type 2 DM patients. Ristocetin heat shock protein family B (small) member 1 Homo sapiens